Re: Tundup's message
|
2
|
Resverlogix Corp.
|
Apr 14, 2019 06:07PM
|
ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
4
|
Resverlogix Corp.
|
Apr 14, 2019 09:23AM
|
Re: Tundup's message
|
5
|
Resverlogix Corp.
|
Apr 14, 2019 07:39AM
|
Re: Statistical Significance
|
3
|
Resverlogix Corp.
|
Apr 13, 2019 02:36PM
|
Re: Tundup's message
|
5
|
Resverlogix Corp.
|
Apr 13, 2019 10:40AM
|
Re: Tundup's message
|
3
|
Resverlogix Corp.
|
Apr 13, 2019 10:31AM
|
Re: Statistical Significance
|
3
|
Resverlogix Corp.
|
Apr 13, 2019 10:21AM
|
Re: Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 12:06PM
|
Re: Upcoming CVOT results
|
5
|
Resverlogix Corp.
|
Apr 12, 2019 11:41AM
|
Re: Upcoming CVOT results
|
3
|
Resverlogix Corp.
|
Apr 12, 2019 10:53AM
|
Re: Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 10:44AM
|
Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 10:08AM
|
Re: HL USA - Material or not?
|
3
|
Resverlogix Corp.
|
Apr 11, 2019 06:12PM
|
Re: DENALI
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 11, 2019 10:25AM
|
Re: Not much happening these days regarding share price
|
4
|
Resverlogix Corp.
|
Apr 10, 2019 02:17PM
|
Updated List of BET inhibitors
|
7
|
Zenith Epigenetics
|
Apr 10, 2019 02:03PM
|
April Fact Sheet
|
4
|
Resverlogix Corp.
|
Apr 10, 2019 09:20AM
|
Re: Epigenetics: an exciting new approach in prostate cancer
|
4
|
Zenith Epigenetics
|
Apr 10, 2019 09:15AM
|
Re: Apabetalone......a Calculated Risk
|
6
|
Resverlogix Corp.
|
Apr 09, 2019 07:23PM
|
Re: AACR
|
2
|
Zenith Epigenetics
|
Apr 09, 2019 11:36AM
|